Augmedix, Inc. (AUGX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch AUGX
See up to 3 months of AUGX. The 7-day demo opens the 1M and 3M ranges and puts AUGX on your watchlist.
Start 7-day demoLatest AUGX insider trades
About Augmedix, Inc. (AUGX)
Augmedix, Inc. is an SEC registrant, filing under CIK 0001769804, classified as business services, nec. It is grouped with Information Technology companies on this site.
AUGX Form 4 activity by transaction type, last 90 days
No Form 4 activity for AUGX in the last 90 days.
AUGX insider transactions (Form 4)
6314 Form 4 filings on record, the earliest from Oct 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tomer Levy - Officer | Derivative | Restricted Stock Units | 105,000 | $0.00 | - | |
| Saurav Chatterjee - Officer | Derivative | Common Stock | 5,844 | $2.35 | $14K | |
| Saurav Chatterjee - Officer | Derivative | Employee Stock Option (right to buy) | 70,000 | $0.00 | - | |
| Saurav Chatterjee - Officer | Derivative | Employee Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Saurav Chatterjee - Officer | Derivative | Employee Stock Option (right to buy) | 37,263 | $0.00 | - | |
| Saurav Chatterjee - Officer | Derivative | Employee Stock Option (right to buy) | 14,732 | $0.00 | - | |
| Saurav Chatterjee - Officer | Derivative | Employee Stock Option (right to buy) | 294,635 | $0.00 | - | |
| Saurav Chatterjee - Officer | Derivative | Restricted Stock Units | 65,625 | $0.00 | - | |
| Sandra Breber - Officer | Derivative | Common Stock | 20,295 | $2.35 | $48K | |
| Sandra Breber - Officer | Derivative | Employee Stock Option (right to buy) | 70,000 | $0.00 | - | |
| Sandra Breber - Officer | Derivative | Employee Stock Option (right to buy) | 225,000 | $0.00 | - | |
| Sandra Breber - Officer | Derivative | Employee Stock Option (right to buy) | 142,149 | $0.00 | - | |
| Sandra Breber - Officer | Derivative | Employee Stock Option (right to buy) | 115,737 | $0.00 | - | |
| Sandra Breber - Officer | Derivative | Employee Stock Option (right to buy) | 178,867 | $0.00 | - | |
| Sandra Breber - Officer | Derivative | Restricted Stock Units | 87,500 | $0.00 | - | |
| Roderick H. O'Reilly - Director | Derivative | Common Stock | 21,598 | $2.35 | $51K | |
| Roderick H. O'Reilly - Director | Derivative | Employee Stock Option (right to buy) | 370,000 | $0.00 | - | |
| Paul Ginocchio - Officer | Derivative | Common Stock | 135,795 | $2.35 | $319K | |
| Paul Ginocchio - Officer | Derivative | Employee Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Paul Ginocchio - Officer | Derivative | Employee Stock Option (right to buy) | 125,000 | $0.00 | - | |
| Paul Ginocchio - Officer | Derivative | Employee Stock Option (right to buy) | 112,430 | $0.00 | - | |
| Paul Ginocchio - Officer | Derivative | Employee Stock Option (right to buy) | 233,333 | $0.00 | - | |
| Paul Ginocchio - Officer | Derivative | Restricted Stock Units | 87,500 | $0.00 | - | |
| Jason Krikorian - Director | Derivative | Common Stock | 74,230 | $2.35 | $174K | |
| Jonathan Hawkins - Officer | Derivative | Common Stock | 5,844 | $2.35 | $14K | |
| Jonathan Hawkins - Officer | Derivative | Employee Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Jonathan Hawkins - Officer | Derivative | Employee Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Jonathan Hawkins - Officer | Derivative | Employee Stock Option (right to buy) | 79,695 | $0.00 | - | |
| Jonathan Hawkins - Officer | Derivative | Employee Stock Option (right to buy) | 86,697 | $0.00 | - | |
| Jonathan Hawkins - Officer | Derivative | Employee Stock Option (right to buy) | 88,381 | $0.00 | - | |
| Jonathan Hawkins - Officer | Derivative | Restricted Stock Units | 65,625 | $0.00 | - | |
| Ian Shakil - Officer | Derivative | Common Stock | 7,701 | $2.35 | $18K | |
| Ian Shakil - Officer | Derivative | Employee Stock Option (right to buy) | 455,949 | $0.00 | - | |
| Ian Shakil - Officer | Derivative | Employee Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Ian Shakil - Officer | Derivative | Employee Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Ian Shakil - Officer | Derivative | Employee Stock Option (right to buy) | 40,000 | $0.00 | - | |
| Ian Shakil - Officer | Derivative | Employee Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Ian Shakil - Officer | Derivative | Employee Stock Option (right to buy) | 47,239 | $0.00 | - | |
| Ian Shakil - Officer | Derivative | Restricted Stock Units | 52,500 | $0.00 | - | |
| Ian Shakil - Officer | Derivative | Restricted Stock Units | 56,250 | $0.00 | - | |
| Emmanuel Krakaris - Officer | Derivative | Common Stock | 64,748 | $2.35 | $152K | |
| Emmanuel Krakaris - Officer | Derivative | Employee Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Emmanuel Krakaris - Officer | Derivative | Employee Stock Option (right to buy) | 325,000 | $0.00 | - | |
| Emmanuel Krakaris - Officer | Derivative | Employee Stock Option (right to buy) | 46,273 | $0.00 | - | |
| Emmanuel Krakaris - Officer | Derivative | Employee Stock Option (right to buy) | 363,961 | $0.00 | - | |
| Emmanuel Krakaris - Officer | Derivative | Employee Stock Option (right to buy) | 800,820 | $0.00 | - | |
| Emmanuel Krakaris - Officer | Derivative | Employee Stock Option (right to buy) | 831,637 | $0.00 | - | |
| Emmanuel Krakaris - Officer | Derivative | Employee Stock Option (right to buy) | 505,036 | $0.00 | - | |
| Emmanuel Krakaris - Officer | Derivative | Restricted Stock Units | 131,250 | $0.00 | - | |
| Robert C. Faulkner - Director | Derivative | Common Stock | 41,461 | $2.35 | $97K | |
| Margie L. Traylor - Director | Derivative | Common Stock | 124,127 | $2.35 | $292K | |
| Margie L. Traylor - Director | Derivative | Employee Stock Option (right to buy) | 25,454 | $0.00 | - | |
| Redmile Group, LLC - Director | Derivative | Common Stock | 16,421,788 | $2.35 | $38.59M | |
| Redmile Group, LLC - Director | Derivative | Common Stock | 9,446,146 | $2.35 | $22.20M | |
| Redmile Group, LLC - Director | Derivative | Common Stock | 6,218,238 | $2.35 | $14.61M | |
| Redmile Group, LLC - Director | Derivative | Pre-Funded Warrants to Purchase Common Stock | 3,125,195 | - | - | |
| Redmile Group, LLC - Director | Derivative | Pre-Funded Warrants to Purchase Common Stock | 3,125,195 | - | - | |
| Redmile Group, LLC - Director | Derivative | Breakeven Warrants | 1,093,799 | - | - | |
| Redmile Group, LLC - Director | Derivative | Breakeven Warrants | 1,093,799 | - | - | |
| William J. Febbo - Director | Derivative | Common Stock | 162,583 | $2.35 | $382K | |
| William J. Febbo - Director | Derivative | Employee Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Laurie McGraw - Director | Derivative | Common Stock | 74,230 | $2.35 | $174K | |
| Laurie McGraw - Director | Derivative | Employee Stock Option (right to buy) | 18,817 | $0.00 | - |
AUGX insider trading FAQ
What is the latest insider trade for AUGX?
Augmedix, Inc. (AUGX) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-10-04. The full record for AUGX runs to 14 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AUGX stock?
No insider purchases of AUGX were filed in the last 90 days.
How many insiders are selling AUGX stock?
No insider sales of AUGX were filed in the last 90 days.
Where can I see AUGX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AUGX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Information Technology companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Tomer Levy view on EDGAR
- - Saurav Chatterjee view on EDGAR
- - Sandra Breber view on EDGAR
- - Roderick H. O'Reilly view on EDGAR
- - Paul Ginocchio view on EDGAR
- - Jason Krikorian view on EDGAR
- - Jonathan Hawkins view on EDGAR
- - Ian Shakil view on EDGAR
- - Emmanuel Krakaris
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Information Technology
- Where AUGX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AUGX with a 7-day demo
- AUGX on your watchlist
- Every AUGX Form 4 filing on record
- Up to 3 months of AUGX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
